Guardian Pharmacy Services, Inc. (NYSE:GRDN – Get Free Report) has received an average rating of “Moderate Buy” from the ten ratings firms that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $45.57.
Several analysts have recently issued reports on the company. Wall Street Zen upgraded Guardian Pharmacy Services from a “hold” rating to a “buy” rating in a research report on Saturday. Oppenheimer increased their price objective on Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a research note on Friday, August 7th. Truist Financial lifted their price objective on Guardian Pharmacy Services from $47.00 to $51.00 and gave the stock a “buy” rating in a research report on Monday, September 21st. KeyCorp began coverage on shares of Guardian Pharmacy Services in a research note on Tuesday, September 22nd. They issued an “overweight” rating and a $52.00 target price for the company. Finally, Weiss Ratings raised shares of Guardian Pharmacy Services from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, November 9th.
View Our Latest Stock Analysis on GRDN
Guardian Pharmacy Services Stock Up 0.4%
Shares of Guardian Pharmacy Services stock traded up $0.18 during trading on Tuesday, hitting $49.56. 339,069 shares of the company were exchanged, compared to its average volume of 508,603. Guardian Pharmacy Services has a fifty-two week low of $26.34 and a fifty-two week high of $50.58. The stock has a market capitalization of $3.14 billion, a price-to-earnings ratio of 42.36, a P/E/G ratio of 2.58 and a beta of 0.06. The firm has a 50 day moving average price of $42.48 and a 200 day moving average price of $38.78.
Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last posted its earnings results on Thursday, November 5th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.02. The firm had revenue of $371.07 million for the quarter, compared to analyst estimates of $365.76 million. Guardian Pharmacy Services had a return on equity of 30.29% and a net margin of 5.13%. Analysts predict that Guardian Pharmacy Services will post 1.18 earnings per share for the current year.
Institutional Investors Weigh In On Guardian Pharmacy Services
Hedge funds and other institutional investors have recently modified their holdings of the company. First Trust Advisors LP lifted its stake in shares of Guardian Pharmacy Services by 30.3% during the third quarter. First Trust Advisors LP now owns 601,238 shares of the company’s stock valued at $24,518,000 after buying an additional 139,931 shares during the period. Voya Investment Management LLC purchased a new stake in Guardian Pharmacy Services in the 3rd quarter worth approximately $238,000. Teachers Retirement System of The State of Kentucky grew its stake in Guardian Pharmacy Services by 54.7% in the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 38,372 shares of the company’s stock worth $1,565,000 after acquiring an additional 13,572 shares during the period. Bessemer Group Inc. grew its stake in Guardian Pharmacy Services by 3.2% in the 3rd quarter. Bessemer Group Inc. now owns 565,598 shares of the company’s stock worth $23,064,000 after acquiring an additional 17,569 shares during the period. Finally, Riverbridge Partners LLC raised its holdings in Guardian Pharmacy Services by 4.1% in the 3rd quarter. Riverbridge Partners LLC now owns 254,630 shares of the company’s stock valued at $10,384,000 after acquiring an additional 10,045 shares during the last quarter.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc. provides pharmacy services to people living in long-term care and residential care settings. Its customers include assisted living and skilled nursing communities, behavioral health facilities, and other group-living providers. The company supplies prescription medications and offers medication packaging, delivery, consulting, and clinical support. Its services are designed to help care providers manage residents’ medication needs and support continuity of care. Founded in 2004, Guardian operates a network of pharmacies serving communities across the United States.
Featured Stories
- Five stocks we like better than Guardian Pharmacy Services
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
